Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Other Operating Expenses: 2022-2025

Historic Other Operating Expenses for Gossamer Bio (GOSS) over the last 2 years, with Sep 2025 value amounting to $7.5 million.

  • Gossamer Bio's Other Operating Expenses was N/A to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.5 million, marking a year-over-year change of. This contributed to the annual value of $10.0 million for FY2023, which is 15284.62% up from last year.
  • Gossamer Bio's Other Operating Expenses amounted to $7.5 million in Q3 2025, which was down 25.24% from $10.0 million recorded in Q4 2023.
  • In the past 5 years, Gossamer Bio's Other Operating Expenses ranged from a high of $10.0 million in Q4 2023 and a low of $15,000 during Q2 2022.
  • In the last 2 years, Gossamer Bio's Other Operating Expenses had a median value of $3.7 million in 2023 and averaged $4.4 million.
  • The largest annual percentage gain for Gossamer Bio's Other Operating Expenses in the last 5 years was 66,566.67% (2023), contrasted with its biggest fall of 25.00% (2023).
  • Gossamer Bio's Other Operating Expenses (Quarterly) stood at $15,000 in 2022, then spiked by 66,566.67% to $10.0 million in 2023, then reached $7.5 million in 2025.
  • Its Other Operating Expenses stands at $7.5 million for Q3 2025, versus $10.0 million for Q4 2023 and $15,000 for Q2 2023.